X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

AB 5: When Legislators and Lobbyists Collide

What happens when legislative efforts are met with focused pressure from a variety of industries, ci...

Read More >

Department of Justice fines pharmaceutical company

Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announc...

Read More >

Oregon’s New Paid Family and Medical Leave Act

On the final day of the 2019 legislative session, Oregon approved Senate Bill 2005, the Oregon Famil...

Read More >

More Proof That Environmental Site Assessments Are Critically Important In CERCLA Cases

In 1980, Congress enacted the Comprehensive Environmental Response, Compensation, and Liability Act ...

Read More >

The Recording of Meetings by Employees (and Employers)

In this OnPoint, we report on a recent decision of the UK Employment Appeal Tribunal on the issue of...

Read More >

CARES Act Questions for the Real Estate and Construction Industry - Update #8

Congress recently passed the economic stimulus package referred to as the Coronavirus Aid, Relief, a...

Read More >